Cargando…
Molecular Mechanisms of the Interactions of N-(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins
The binding of plasma proteins to a drug carrier alters the circulation of nanoparticles (NPs) in the bloodstream, and, as a consequence, the anticancer efficiency of the entire nanoparticle drug delivery system. We investigate the possible interaction and the interaction mechanism of a polymeric dr...
Autores principales: | Janisova, Larisa, Gruzinov, Andrey, Zaborova, Olga V., Velychkivska, Nadiia, Vaněk, Ondřej, Chytil, Petr, Etrych, Tomáš, Janoušková, Olga, Zhang, Xiaohan, Blanchet, Clement, Papadakis, Christine M., Svergun, Dmitri I., Filippov, Sergey K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076460/ https://www.ncbi.nlm.nih.gov/pubmed/32013056 http://dx.doi.org/10.3390/pharmaceutics12020106 |
Ejemplares similares
-
Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer Treatment
por: Etrych, Tomáš, et al.
Publicado: (2019) -
N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.
por: Seymour, L. W., et al.
Publicado: (1991) -
N-(2-hydroxypropyl)methacrylamide–amphotericin B (HPMA–AmB) copolymer conjugates as antileishmanial agents
por: Nicoletti, Salvatore, et al.
Publicado: (2009) -
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.
por: Duncan, R., et al.
Publicado: (1987) -
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.
por: Duncan, R., et al.
Publicado: (1988)